Global Liposomes Drug Delivery Market Research Report 2015-2025
- HEY3759026
- 88 Pages
- February 2020
- Healthcare
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Liposomal doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Johnson & Johnson
Gilead Sciences
Luye Pharma
Sun Pharmaceutical
Pacira
Fudan-Zhangjiang
Sigma-Tau Group
Teva Pharmaceutical
CSPC
Novartis
Crucell
Celsion Corporation
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Fungal Infection Therapy
Cancer Therapy ( Tumor therapy)
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Liposomes Drug Delivery Picture
1.1.2 Specifications
Table Product Specifications of Liposomes Drug Delivery
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Liposomes Drug Delivery
Table Global Liposomes Drug Delivery Market by Type, 2011-2022 (USD Million)
1.2.1.1 Liposomal doxorubicin
Table Liposomal doxorubicin Overview
1.2.1.2 Liposomal Amphoteracin B
Table Liposomal Amphoteracin B Overview
1.2.1.3 Liposomal Paclitaxel
Table Liposomal Paclitaxel Overview
1.2.1.4 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Liposomes Drug Delivery
Table Global Liposomes Drug Delivery Market by Application, 2011-2022 (USD Million)
1.2.2.1 Fungal Infection Therapy
Table Fungal Infection Therapy Overview
1.2.2.2 Cancer Therapy ( Tumor therapy)
Table Cancer Therapy ( Tumor therapy) Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Liposomes Drug Delivery Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Liposomes Drug Delivery
2.2 Upstream
Table Cost of Liposomes Drug Delivery
Figure Manufacturing Process of Liposomes Drug Delivery
2.3 Market
2.3.1 SWOT
Figure SWOT of Liposomes Drug Delivery
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Liposomes Drug Delivery
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Liposomes Drug Delivery
3.4 Market Entry
Table Market Entry of Liposomes Drug Delivery
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Liposomal doxorubicin Market, 2013-2018
Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (in Volume)
Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2018
4.1.2 Liposomal Amphoteracin B Market, 2013-2018
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (in Volume)
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2018
4.1.3 Liposomal Paclitaxel Market, 2013-2018
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (in Volume)
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2018
4.1.4 Others Market, 2013-2018
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2018
4.2 Market Forecast
4.2.1 Liposomal doxorubicin Market Forecast, 2020-2025
Figure Liposomal doxorubicin Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Liposomal doxorubicin Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2024
4.2.2 Liposomal Amphoteracin B Market Forecast, 2020-2025
Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2024
4.2.3 Liposomal Paclitaxel Market Forecast, 2020-2025
Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2024
4.2.4 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Fungal Infection Therapy Market, 2013-2018
Figure Fungal Infection Therapy Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Fungal Infection Therapy CAGR by Revenue and Volume, 2012-2018
5.1.2 Cancer Therapy ( Tumor therapy) Market, 2013-2018
Figure Cancer Therapy ( Tumor therapy) Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Cancer Therapy ( Tumor therapy) CAGR by Revenue and Volume, 2012-2018
5.1.3 Others Market, 2013-2018
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2018
5.2 Market Forecast
5.2.1 Fungal Infection Therapy Market Forecast, 2020-2025
Figure Fungal Infection Therapy Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Fungal Infection Therapy Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Fungal Infection Therapy CAGR by Revenue and Volume, 2020-2025
5.2.2 Cancer Therapy ( Tumor therapy) Market Forecast, 2020-2025
Figure Cancer Therapy ( Tumor therapy) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Cancer Therapy ( Tumor therapy) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Cancer Therapy ( Tumor therapy) CAGR by Revenue and Volume, 2020-2025
5.2.3 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Table North America CAGR by Revenue and Volume, 2012-2018
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Table Europe CAGR by Revenue and Volume, 2012-2018
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Table South America CAGR by Revenue and Volume, 2012-2018
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Liposomes Drug Delivery Market by Vendors, 2012-2018 (in Volume)
Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (USD Million)
Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (in Volume)
7.2 Market Concentration
Figure Liposomes Drug Delivery Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Johnson & Johnson
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Gilead Sciences
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Luye Pharma
Table Luye Pharma Profile List
Table Microecological Modulator Operating Data of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Sun Pharmaceutical
Table Sun Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Pacira
Table Pacira Profile List
Table Microecological Modulator Operating Data of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Fudan-Zhangjiang
Table Fudan-Zhangjiang Profile List
Table Microecological Modulator Operating Data of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Sigma-Tau Group
Table Sigma-Tau Group Profile List
Table Microecological Modulator Operating Data of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Teva Pharmaceutical
Table Teva Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 CSPC
Table CSPC Profile List
Table Microecological Modulator Operating Data of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Crucell
Table Crucell Profile List
Table Microecological Modulator Operating Data of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Celsion Corporation
Table Celsion Corporation Profile List
Table Microecological Modulator Operating Data of Celsion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Kingond Pharm
Table Kingond Pharm Profile List
Table Microecological Modulator Operating Data of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Shanghai New Asia
Table Shanghai New Asia Profile List
Table Microecological Modulator Operating Data of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Spectrum Pharmaceuticals
Table Spectrum Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Liposomes Drug Delivery
Table Products Segment of Liposomes Drug Delivery
Table Global Liposomes Drug Delivery Market by Type, 2011-2022 (USD Million)
Table Liposomal doxorubicin Overview
Table Liposomal Amphoteracin B Overview
Table Liposomal Paclitaxel Overview
Table Others Overview
Table Application Segment of Liposomes Drug Delivery
Table Global Liposomes Drug Delivery Market by Application, 2011-2022 (USD Million)
Table Fungal Infection Therapy Overview
Table Cancer Therapy ( Tumor therapy) Overview
Table Others Overview
Table Global Liposomes Drug Delivery Market by Region, 2011-2022 (USD Million)
Table Cost of Liposomes Drug Delivery
Table Market Dynamics
Table Policy of Liposomes Drug Delivery
Table GDP of Major Countries
Table Technology of Liposomes Drug Delivery
Table Market Entry of Liposomes Drug Delivery
Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2018
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2018
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2024
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2024
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Fungal Infection Therapy CAGR by Revenue and Volume, 2012-2018
Table Cancer Therapy ( Tumor therapy) CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Fungal Infection Therapy CAGR by Revenue and Volume, 2020-2025
Table Cancer Therapy ( Tumor therapy) CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
Table North America CAGR by Revenue and Volume, 2012-2018
Table Europe CAGR by Revenue and Volume, 2012-2018
Table South America CAGR by Revenue and Volume, 2012-2018
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Liposomes Drug Delivery Market by Vendors, 2012-2018 (in Volume)
Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (USD Million)
Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luye Pharma Profile List
Table Microecological Modulator Operating Data of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pacira Profile List
Table Microecological Modulator Operating Data of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fudan-Zhangjiang Profile List
Table Microecological Modulator Operating Data of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sigma-Tau Group Profile List
Table Microecological Modulator Operating Data of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSPC Profile List
Table Microecological Modulator Operating Data of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Crucell Profile List
Table Microecological Modulator Operating Data of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celsion Corporation Profile List
Table Microecological Modulator Operating Data of Celsion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kingond Pharm Profile List
Table Microecological Modulator Operating Data of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shanghai New Asia Profile List
Table Microecological Modulator Operating Data of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
